Weekly Update:
S&P 500 868.60 +5.17%
NASDAQ 1,591.71 +7.81%
Russell 2000 470.70 +6.13%
MSCI Emerging Markets 24.55 +7.88%
Much attention will focus on issues and reactions to government's plan. This weekend's discussion on the stimulus package should set the overall market tone. Last week, a mystifying result for participants given weak economic numbers and a positive stock market return. From a long-term view, these series of event fail to provide clear clues. For the most part, it seems like a speculators market where long-term participants struggle to find substantial data points. In one sense, economic data signaling bad news is becoming less of a reactionary event. As volatility stabilizes, its visible that few sentiment indicators such as the Baltic Dry index, and Weekly Mortgage applications, are conveying a message of hope; which reminds us that's its purely an anticipation of a desired outcome. The current financial status, reflects that investor confidence is tilting in the hands of policymakers. Similarly, fundamentals are taking a back seat from being a main driver of market reactions.
A visual look at the chart of the S&P 500 reminds us of a sideway pattern. That begs the question, if this directional pause is a temporary or further declines await? Current cycle junction points to excess of capital that's flowing out of the system. Simply, a movement away from leverage and more into government spending. For participants, the concept of temporary optimism has been a trend within an existing downtrend. Oddly enough, existing consensus is to go long banks, homebuilders and select consumer themes. Nonetheless, sole dependence on newsflow presents surprises and potential risk. On the other hand, Gold is demonstrating a noticeable recovery. Perhaps some will argue this implies a defensive posture amoung global participants. Interestingly, plenty of mixed signals in credit and commodity markets but a deadlock in confidence restoration.
Stock Specific:
WTR (Aqua America): Positive trend since summer 2008. Utilities are poised to benefit from a defensive spending. Recent increase in dividends raise yields to 3.20% can spark interest among buyers.
SXE (Stanley Inc): Company benefits from defense spending and recent quarter showcased further strength. Major support around $30.
Healthcare:
· HUM (Humana) : Strength developing and showcased in recent recovery from lows of $22.30. From a long term view, earnings are growing at a healthy pace exceeding expectations.
· EW (Edward Life Science): Doubled profits last quarter sending a positive signal. Approaching 52 week high of $66 serving as the next key target.
· VRTX (Vertex Pharma): Poised for pullbacks around $36. Pending declines offer entry points for sustainable upside move.
Biotech: Current atmosphere offers few ideas with favorable cycle, policies and investor demand. Again, relative strength in biotech stands out. An attractive entry point given opportunities for innovation and growth potential.
Macro Points:
S&P 500 [ 868.60] A 3+ month trading range between 800-900. For those keeping scores, the index is 22.6% removed from its 200 day average.
Crude [$40.17] Heavy resistance at $50 and most buyers appear interested below $40. This recent trend should be tested in weeks ahead.
Gold [$913.00] Defined uptrend from late October lows of $712.50. On the positive side, last week's action broke above previous highs of $905. Next key upside level stands at $1011.
US 10 Year Yields [2.99%] Early indication of a trend as yields increased from 2.40%. Potential near-term pullbacks at current levels.
DXY US Dollar [85.35] An 8 + month upside trend, that started in March 2008, is positive especially above 80. Recent month have seen index pause at the 86 range, which signifies a resistance point.
The positions and strategies discussed on MarketTakers are offered for entertainment purposes only and are in no way intended to serve as personal investing advice. Readers should not make any investment decision without first conducting their own thorough due diligence. Readers should assume the editor holds a position in any securities discussed, recommended or panned. While the information provided is obtained from sources believed to be reliable, its accuracy or completeness cannot be guaranteed, nor can this publication be, in any way, considered liable for the future investment performance of any securities or strategies discussed.